Delivery Order SPE2DB24D2212-SPE2DB24FHMXJ
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,016,626 units of Losartan Potassium 50 mg tablets. The contract has a ceiling value of $1,071.94 and a period of performance through March 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 with a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,564,840 units of Losartan Potassium 100 mg tablets. The contract has a ceiling value of $2,179.10 and a completion date of June 10, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to...
- This federal contract award is for the delivery of Losartan Potassium 100 mg tablets in quantities of 1,000 to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary...
- This federal contract award is for the delivery of Losartan Potassium 100 mg tablets in 1,000-unit quantities. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price type and has a ceiling value of $4,735.63. The contract has an ultimate completion date of December 16, 2024 and was awarded on December 13, 2024. The place of performance is...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,557,681,068 units of Losartan Potassium 100 mg tablets. The $6,391.66 firm fixed-price contract was awarded on June 29, 2022 by the Defense Logistics Agency (DLA), with a performance period ending on June 30, 2022. The award is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,796,057 units of Losartan Potassium 100mg tablets, valued at $1,877.22. It is a firm fixed-price delivery order contract with an ultimate completion date of April 4, 2025. This award is not associated with a set-aside designation. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award, with ID SPE2DB24D1205|SPE2DB25FCWAT, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,985,206 units of Losartan Potassium 100 mg tablets in 1,000-count containers. The contract has a ceiling value of $3,024.43 and a completion date of April 22, 2025. It is a firm-fixed-price delivery order contract, without any set-aside designation. AmerisourceBergen Drug...
- This federal contract award, with a ceiling value of $2,153.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Losartan Potassium 100 mg tablets, with a period of performance through May 26, 2023. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of Losartan Potassium 25 mg Tablets in quantities of 1,000 to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 27, 2021, with a ceiling value of $1,663.93 and a completion date of September 28, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent...
- This federal contract award is for the delivery of Losartan Potassium 100 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $3,965.18, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a completion date of March 1, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB24FHMXJDelivery Order
This federal contract award is for the delivery of 4,564,996,243 units of Losartan Potassium 100 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $6,355.23 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 25, 2024, with a completion date of June 26, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 6/25/24 |